Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2022 Filed Oct 4, 2022 20:14 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GrantCommon Stock | 26 | $76.16 | $1,980.16 |
DisclosureSEC source: 0001127602-22-023446 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,260 Read SEC document |
| September 15, 2022 Filed Sep 16, 2022 22:16 UTC |
Hartman Curt RDirector · President, CEO and Chair
|
SaleCommon Stock | 3,500 | $93.94 | $328,776.00 |
DisclosureSEC source: 0001127602-22-022564 · form4.xml · nonDerivative · entry 1 Hartman Curt R · CIK 0001451535 · Director · President, CEO and Chair 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,299 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.81 to $94.03. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 01:01 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionOptions To Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-22-020992 · form4.xml · derivative · entry 3 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 7,500 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 01:01 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
SaleCommon Stock | 7,500 | $100.90 | $756,750.00 |
DisclosureSEC source: 0001127602-22-020992 · form4.xml · nonDerivative · entry 2 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63 Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 01:01 UTC |
Peters Stanley W IIIVP GM Advanced Surgery
|
Exercise / conversionCommon Stock | 7,500 | $41.93 | $314,475.00 |
DisclosureSEC source: 0001127602-22-020992 · form4.xml · nonDerivative · entry 1 Peters Stanley W III · CIK 0001635365 · VP GM Advanced Surgery 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 19:07 UTC |
Cohen Heather LEVP CORP HR
|
Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 5,000 | $0.00 Strike: $32.93 | $0.00 |
DisclosureSEC source: 0001127602-22-020869 · form4.xml · derivative · entry 3 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 19:07 UTC |
Cohen Heather LEVP CORP HR
|
Tax withholdingCommon Stock | 2,847 | $100.85 | $287,119.95 |
DisclosureSEC source: 0001127602-22-020869 · form4.xml · nonDerivative · entry 2 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,778 Read SEC document |
| August 10, 2022 Filed Aug 12, 2022 19:07 UTC |
Cohen Heather LEVP CORP HR
|
Exercise / conversionCommon Stock | 5,000 | $32.93 | $164,650.00 |
DisclosureSEC source: 0001127602-22-020869 · form4.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 30, 2022 Filed Jul 6, 2022 20:11 UTC |
Jonas Daniel SEVP Legal Affairs,Gen. Counsel
|
GrantCommon Stock | 22 | $90.97 | $2,001.34 |
DisclosureSEC source: 0001127602-22-018923 · form4.xml · nonDerivative · entry 1 Jonas Daniel S · CIK 0001238334 · EVP Legal Affairs,Gen. Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,234 Read SEC document |
| June 30, 2022 Filed Jul 7, 2022 19:31 UTC |
Cohen Heather LEVP CORP HR
|
GrantCommon Stock | 1 | $90.97 | $90.97 |
DisclosureSEC source: 0001127602-22-019040 · form4.xml · nonDerivative · entry 1 Cohen Heather L · CIK 0001436649 · EVP CORP HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,625 Read SEC document |
| June 30, 2022 Filed Jul 7, 2022 19:37 UTC |
Garner Todd WExecutive Vice President & CFO
|
GrantCommon Stock | 1 | $90.97 | $90.97 |
DisclosureSEC source: 0001127602-22-019041 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 Read SEC document |
| June 30, 2022 Filed Jul 7, 2022 19:28 UTC |
Lalomia BrentVice President QA and RA
|
OtherCommon Stock | 0.737 | $97.69 | $72.00 |
DisclosureSEC source: 0001127602-22-019039 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 678.737 F1 · kind: The acquisition was pursuant to a written plan. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 01:55 UTC |
Lalomia BrentVice President QA and RA
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017957 · form4.xml · derivative · entry 3 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2029-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 01:55 UTC |
Lalomia BrentVice President QA and RA
|
Tax withholdingCommon Stock | 72 | $88.93 | $6,402.96 |
DisclosureSEC source: 0001127602-22-017957 · form4.xml · nonDerivative · entry 2 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 678 Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 01:55 UTC |
Lalomia BrentVice President QA and RA
|
Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-017957 · form4.xml · nonDerivative · entry 1 Lalomia Brent · CIK 0001921560 · Vice President QA and RA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 01:12 UTC |
Garner Todd WExecutive Vice President & CFO
|
SaleCommon Stock | 2,662 | $99.79 | $265,640.98 |
DisclosureSEC source: 0001127602-22-017504 · form4.xml · nonDerivative · entry 1 Garner Todd W · CIK 0001726884 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported was effected pursuant to a previously adopted Rule 10b5-1 Trading Plan. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:29 UTC |
Workman John LDirector
|
GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016541 · form4.xml · derivative · entry 4 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:29 UTC |
Workman John LDirector
|
GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016541 · form4.xml · derivative · entry 3 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:29 UTC |
Workman John LDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016541 · form4.xml · derivative · entry 2 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:29 UTC |
Workman John LDirector
|
Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016541 · form4.xml · nonDerivative · entry 1 Workman John L · CIK 0001302537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:26 UTC |
Schwarzentraub Barbara JDirector
|
GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016540 · form4.xml · derivative · entry 4 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:26 UTC |
Schwarzentraub Barbara JDirector
|
GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016540 · form4.xml · derivative · entry 3 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:26 UTC |
Schwarzentraub Barbara JDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016540 · form4.xml · derivative · entry 2 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:26 UTC |
Schwarzentraub Barbara JDirector
|
Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016540 · form4.xml · nonDerivative · entry 1 Schwarzentraub Barbara J · CIK 0001788466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:23 UTC |
Lande Jerome J.Director
|
GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016539 · form4.xml · derivative · entry 4 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:23 UTC |
Lande Jerome J.Director
|
GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016539 · form4.xml · derivative · entry 3 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:23 UTC |
Lande Jerome J.Director
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016539 · form4.xml · derivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:23 UTC |
Lande Jerome J.Director
|
Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016539 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:17 UTC |
Council LaVerne HDirector
|
GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016537 · form4.xml · derivative · entry 4 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:17 UTC |
Council LaVerne HDirector
|
GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016537 · form4.xml · derivative · entry 3 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:17 UTC |
Council LaVerne HDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016537 · form4.xml · derivative · entry 2 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:17 UTC |
Council LaVerne HDirector
|
Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016537 · form4.xml · nonDerivative · entry 1 Council LaVerne H · CIK 0001788616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:20 UTC |
Farkas CharlesDirector
|
GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016538 · form4.xml · derivative · entry 4 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:20 UTC |
Farkas CharlesDirector
|
GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016538 · form4.xml · derivative · entry 3 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:20 UTC |
Farkas CharlesDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016538 · form4.xml · derivative · entry 2 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:20 UTC |
Farkas CharlesDirector
|
Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016538 · form4.xml · nonDerivative · entry 1 Farkas Charles · CIK 0001615538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:14 UTC |
Concannon BrianDirector
|
GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016535 · form4.xml · derivative · entry 4 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:14 UTC |
Concannon BrianDirector
|
GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016535 · form4.xml · derivative · entry 3 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:14 UTC |
Concannon BrianDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016535 · form4.xml · derivative · entry 2 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:14 UTC |
Concannon BrianDirector
|
Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016535 · form4.xml · nonDerivative · entry 1 CONCANNON BRIAN · CIK 0001261784 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:12 UTC |
Bronson David M.Director
|
GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016533 · form4.xml · derivative · entry 4 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:12 UTC |
Bronson David M.Director
|
GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016533 · form4.xml · derivative · entry 3 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:12 UTC |
Bronson David M.Director
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016533 · form4.xml · derivative · entry 2 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:12 UTC |
Bronson David M.Director
|
Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016533 · form4.xml · nonDerivative · entry 1 BRONSON DAVID M · CIK 0001183762 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:09 UTC |
Aronson Martha GoldbergDirector
|
GrantRsus (restricted Stock Units) · Derivative | 335 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016531 · form4.xml · derivative · entry 4 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335 Underlying: Common Stock · 335 shares Expires 2032-06-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:09 UTC |
Aronson Martha GoldbergDirector
|
GrantOptions To Purchase Common Stock · Derivative | 3,453 | $0.00 Strike: $111.79 | $0.00 |
DisclosureSEC source: 0001127602-22-016531 · form4.xml · derivative · entry 3 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,453 Underlying: Common Stock · 3,453 shares Expires 2032-06-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:09 UTC |
Aronson Martha GoldbergDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016531 · form4.xml · derivative · entry 2 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:09 UTC |
Aronson Martha GoldbergDirector
|
Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016531 · form4.xml · nonDerivative · entry 1 Aronson Martha Goldberg · CIK 0001429832 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,275 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 13:22 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionRsus (restricted Stock Units) · Derivative | 812 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016557 · form4.xml · derivative · entry 2 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 812 shares Expires 2031-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 13:22 UTC |
TRYNISKI MARK EDirector
|
Exercise / conversionCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-016557 · form4.xml · nonDerivative · entry 1 TRYNISKI MARK E · CIK 0001242753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.